Does MIRVASO Cause Application site erythema? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Application site erythema have been filed in association with MIRVASO. This represents 1.4% of all adverse event reports for MIRVASO.
6
Reports of Application site erythema with MIRVASO
1.4%
of all MIRVASO reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site erythema From MIRVASO?
Of the 6 reports.
Is Application site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRVASO. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does MIRVASO Cause?
Erythema (260)
Condition aggravated (190)
Flushing (161)
Skin burning sensation (114)
Feeling hot (93)
Rebound effect (89)
Off label use (81)
Rash macular (47)
Pain of skin (43)
Drug ineffective (38)
What Other Drugs Cause Application site erythema?
NICOTINE (2,004)
SUMATRIPTAN (1,875)
INGENOL MEBUTATE (1,373)
BUPRENORPHINE (1,273)
ESTRADIOL (1,117)
MINOXIDIL (1,061)
METHYLPHENIDATE (543)
ESTRADIOL\NORETHINDRONE (533)
FENTANYL (501)
OXYTROL FOR WOMEN (422)
Which MIRVASO Alternatives Have Lower Application site erythema Risk?
MIRVASO vs MISOPROSTOL
MIRVASO vs MOMETASONE
MIRVASO vs MOMETASONE FUROATE
MIRVASO vs MONTELUKAST
MIRVASO vs MORPHINE